Saturday, August 30, 2014

A Few Reasons Why You Would Want To Buy Tesla

The luxury car maker Tesla (TSLA) is on an uptrend. There is no other company that provides electric vehicles in the luxury segment. The success of this automaker is quite evident with its one-year return of 80% for its investors.

Tesla reported its second-quarter results, which was way ahead of Street's estimates. In fact, it is not the first time the company has over-delivered. It beat the estimates in the last five consecutive quarters. Let us explore the quarter in details.

Into the results

Driven by higher demand for its products, revenue stood at $858 million, higher than the year ago top line of $552 million. Also, this number is higher than $810 million, expected by analysts. Higher deliveries of its Model S sedan led to a growth in sales. Tesla delivered a total of 7579 vehicles of Model S and produced a total of 8,763 vehicles, during the quarter. The deliveries were higher than the company's own estimate of 7,500 vehicles. Number of vehicles delivered is indeed an important metric and an uptick in this figure shows growth prospects of the company.

Even the bottom line did well. Adjusted earnings for the quarter stood at $0.11 per share, as compared to the expectation of $0.04 per share. Therefore, the carmaker managed to outperform the consensus in all the key metrics reported.

Road ahead

Further, Tesla has some amazing plans for the future, which will make investors even more confident about the company. First, it has entered into partnership with Panasonic (PMPC), the battery maker, to participate in setting up Gigafactory, the world's largest battery factory in the U.S. This lithium ion battery factory will produce battery cells for 500,000 electronic vehicles on an annual basis. This initiative requires an investment of $5 billion and a total of 6,500 employees.

Also, the luxury carmaker is in plans to make a mass market electric vehicle in the next 3 years. This model, known as the Model 3, will be priced around $35,000 and will be 20% smaller in size. The affordable car will cater to the middle income group people, who are unable to buy expensive Tesla cars. The upcoming Gigafactory will help in this endeavor.

Another new model, called Model X, is expected to hit the market in the spring season of 2015. This news has brought much excitement to people who are eagerly waiting for the new release.

The automaker is also expanding its wings as it gets into new markets. It plans to expand in China, which is the largest luxury car market. This should help in boosting Tesla's revenue. It will also be expanding to Japan in the coming months, which is an important market as well. Further, demand for model S is already on the rise in the existing markets of the U.S. and Europe.

Therefore, the company is confident about its sales outlook of 35,000 vehicles, during the year. Moreover, Tesla expects to produce 9,000 cars and deliver a total of 7,800 cars in the current quarter.

To end up with

Tesla is the leader in the luxury electric car market with very few players matching up to its standards. In fact, it's been 7 years when the company launched a car with 250 mile battery range and no other company has been able to reach the same level since then. The luxury car maker is doing well and is beating its benchmarks each time. Moreover, with the new cars, slated to be launched, and the new Gigafactory on the cards, Tesla looks like a great pick for the long run.

Currently 2.00/512345

Rating: 2.0/5 (1 vote)

Voters:

Friday, August 29, 2014

3 Biotech Stocks Breaking Out on Big Volume

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track big changes in volume activity. Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Major moves in volume can signal unusual activity, such as insider buying or selling -- or buying or selling by "superinvestors."

Read More: Warren Buffett's Top 10 Dividend Stocks

Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst. These types of traders like to get in well before a large spike, so it's always a smart move to monitor unusual volume. That said, remember to combine trend and price action with unusual volume. Put them all together to help you decipher the next big trend for any stock.

With that in mind, let's take a look at several stocks rising on unusual volume recently.

Esperion Therapeutics

Esperion Therapeutics (ESPR), a clinical stage biopharmaceutical company, focuses on the research, development and commercialization of oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers. This stock closed up 4.9% at $14.96 in Wednesday's trading session.

Wednesday's Volume: 55,000

Three-Month Average Volume: 25,616

Volume % Change: 95%

From a technical perspective, ESPR ripped sharply higher here back above both its 200-day moving average at $14.70 and its 50-day moving average at $14.91 with above-average volume. This sharp spike higher briefly pushed shares of ESPR into breakout territory, since the stock flirted with some near-term overhead resistance at $15.13. Shares of ESPR are now starting to trend within range of triggering another big breakout trade. That trade will hit if ESPR manages to take out Wednesday's intraday high at $15.28 and then once it clears more key overhead resistance levels at $15.97 to $16.32 with high volume.

Traders should now look for long-biased trades in ESPR as long as it's trending above Wednesday's intraday low of $14.42 or above some more key near-term support at $13.90 and then once it sustains a move or close above those breakout levels with volume that's near or above 25,616 shares. If that breakout materializes soon, then ESPR will set up to re-test or possibly take out its next major overhead resistance levels at $17 to $18, or even $18.83 to $19.55.

Read More: 8 Stocks George Soros Is Buying

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals (BCRX), a biotechnology company, designs, optimizes and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. This stock closed up 4.9% at $12.86 in Wednesday's trading session.

Wednesday's Volume: 1.43 million

Three-Month Average Volume: 1.23 million

Volume % Change: 50%

From a technical perspective, BCRX ripped higher here and broke out above some near-term overhead resistance at $12.58 with above-average volume. This sharp spike to the upside on Wednesday is now pushing shares of BCRX within range of triggering another big breakout trade. That trade will hit if BCRX manages to take out Wednesday's intraday high of $12.90 to its 52-week high at $13.33 with high volume.

Traders should now look for long-biased trades in BCRX as long as it's trending above Wednesday's intraday low of $12.34 or above $12 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.23 million shares. If that breakout begins soon, then BCRX will set up to enter new 52-week-high territory above $13.33, which is bullish technical price action. Some possible upside targets off that move are $14 to $15.

Read More: Warren Buffett's Top 25 Stocks for 2014

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical (RARE), a development-stage biotechnology company, focuses on the identification, acquisition, development and commercialization of various products for the treatment of rare and ultra-rare diseases in the U.S. This stock closed up 5.3% to $43.76 in Wednesday's trading session.

Wednesday's Volume: 378,000

Three-Month Average Volume: 196,676

Volume % Change: 70%

From a technical perspective, RARE ripped higher here back above its 50-day moving average of $41.06 with above-average volume. This sharp move to the upside on Wednesday is quickly pushing shares of RARE within range of triggering a big breakout trade. That trade will hit if RARE manages to take out some key near-term overhead resistance levels at $44.30 to $44.59 and then above $46 with high volume.

Traders should now look for long-biased trades in RARE as long as it's trending above its 50-day moving average of $41.06 or above some more near-term support at $39.21 and then once it sustains a move or close above those breakout levels with volume that hits near or above 196,676 shares. If that breakout triggers soon, then RARE will set up to re-test or possibly take out its next major overhead resistance levels at $50.91 to $50.93.

To see more stocks rising on unusual volume, check out the Stocks Rising on Unusual Volume portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:



>>5 Dividend Stocks Ready to Pay You More



>>3 Stocks Under $10 to Trade for Breakouts



>>3 Big M&A Stocks on Traders' Radars

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24. 



Sunday, August 24, 2014

Scandal-ridden food processor issues recall

China food fails   China food fails HONG KONG (CNNMoney) There are no Big Macs. There are no Chicken McNuggets. The menu at McDonald's restaurants in China was much slimmer on Monday after a troubled supplier issued a major recall.

At one Beijing location, no burgers or chicken items of any kind were available. Instead, staffers were reduced to offering only pies, hash browns, fries, drinks and ice cream.

"Some restaurants across [China] might be out of stock on certain products," the company said in a statement. "We sincerely apology to customers for the inconvenience and hope to have their understanding."

The Big Mac shortage is the latest twist in a food scare that has tarnished the reputations of fast food giants including McDonald's, Starbucks and Yum Brands in China.

Shanghai Husi, a subsidiary of Illinois-based OSI Group, said Saturday that it would suspend sales and recall all food processed at its Shanghai facility.

Husi did not specify how much food it will recall but promised an internal investigation and new management at the plant. The company also pledged to cooperate with authorities, who have ordered the facility closed and detained five people as part of their own inquires.

The scandal began when Chinese television showed workers at Husi Shanghai handling expired and tainted meat with their bare hands. Workers could be seen processing meat that had fallen on the floor, for example.

It widened as the extent of the company's distribution came to light. Many well-known fast food chains use the plant to supply their Asian operations.

Most have ended their relationship with the company or stopped selling its products. Among them are Yum Brands (YUM) (owner of KFC and Pizza Hut), Burger King (BKW), Papa John's (PZZA) and Starbucks (SBUX).

While many of its fast food rivals have rushed to cut ties with OSI, McDonald's (MCD) said it will continue to do business with the supplier. The American fast food chain will shift its sourcing to a Husi plant in Hebei, before fully transitioning to a new facility in Henan.

The scandal forced McDonald's to pull food from its restaurants in China, Japan and Hong Kong.

-- CNN's Dayu Zhang and CNNMoney's Sophia Yan contributed to this report

Saturday, August 23, 2014

13 “Triple A” Stocks to Buy

RSS Logo Portfolio Grader Popular Posts: Hottest Healthcare Stocks Now – CLDX KND PDLI MNKDHottest Healthcare Stocks Now – LCI HMSY CBPO MNKDHottest Technology Stocks Now – GRUB SMI CSIQ ZNGA Recent Posts: Biggest Movers in Healthcare Stocks Now – PBYI TRNX KERX NBIX Biggest Movers in Technology Stocks Now – FARO LNKD IART CGNX Biggest Movers in Basic Materials Stocks Now – SCCO CCC KRO SMG View All Posts 13 “Triple A” Stocks to Buy

This week, 13 stocks get A’s (“strong buy”) in Portfolio Grader‘s three main grading categories, Total Grade, Overall Fundamental Grade and Quantitative Grade.

These are the best of the best in the entire Portfolio Grader database. This week, there are 4,333 stocks and only these 13 get top marks in all categories to make the elite “Triple A” stocks list. Here they are:

Edwards Group Ltd. ADR (EVAC) is an industrial technology company that manufactures and sells vacuum products and abatement systems. For more information, get Portfolio Grader’s complete analysis of EVAC stock.

Phoenix New Media Ltd. Sponsored ADR Class A (FENG) provides content on an integrated platform across Internet, mobile, and TV channels in the People’'s Republic of China. Shares of the stock have risen 14.3% since January 1. This is better than the S&P 500, which has remained flat. For more information, get Portfolio Grader’s complete analysis of FENG stock.

Michael Kors Holdings Ltd (KORS) engages in the design, marketing, distribution and retailing of branded women'’s apparel and accessories, and men'’s apparel. For more information, get Portfolio Grader’s complete analysis of KORS stock.

Lannett Company, Inc. (LCI) manufactures and distributes pharmaceutical products under its own trade name and under generic names. Stock prices have risen 14.2% since the first of the year. For more information, get Portfolio Grader’s complete analysis of LCI stock.

Packaging Corporation of America (PKG) engages in the manufacture and sale of containerboard and corrugated packaging products for industrial and consumer markets in the United States. Since the start of the year, PKG has increased 6.5%. For more information, get Portfolio Grader’s complete analysis of PKG stock.

Par Pharmaceutical (PRX) develops, manufactures and distributes generic and branded pharmaceuticals in the United States. For more information, get Portfolio Grader’s complete analysis of PRX stock.

Qihoo 360 Technology Co., Ltd. ADR Class A (QIHU) provides Internet and mobile security products in the People’s Republic of China. Shares of QIHU have climbed 26.9% since January 1. For more information, get Portfolio Grader’s complete analysis of QIHU stock.

SouFun Holdings Ltd Sponsored ADR Class A (SFUN) operates a real estate Internet portal, and a home furnishing and improvement website in the People'’s Republic of China. The stock’s trailing PE Ratio is 8.60. For more information, get Portfolio Grader’s complete analysis of SFUN stock.

Santarus, Inc. (SNTS) is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians. For more information, get Portfolio Grader’s complete analysis of SNTS stock.

Constellation Brands, Inc. Class A (STZ) is primarily a wine company that also markets other alcoholic beverages. STZ is up 25.5% since January 1. The stock has a trailing PE Ratio of 8.20. For more information, get Portfolio Grader’s complete analysis of STZ stock.

Ubiquiti Networks, Inc. (UBNT) designs, manufacturers and sells innovative broadband wireless solutions worldwide. For more information, get Portfolio Grader’s complete analysis of UBNT stock.

TAL Education Group Unsponsored ADR Class A (XRS) provides K-12 after-school tutoring services in China. Since the start of the year, XRS has soared 68.3%. For more information, get Portfolio Grader’s complete analysis of XRS stock.

YY, Inc. Sponsored ADR Class A (YY) operates an online social platform in the People’'s Republic of China. Shares of the stock have risen 78% since January 1. The stock’s trailing PE Ratio is 3.80. For more information, get Portfolio Grader’s complete analysis of YY stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.

Sunday, August 17, 2014

VIDEO: The Apple-IBM Partnership

VIDEO: The Apple-IBM Partnership

I joined CNBC's Bernie Lo this evening to discuss Apple (AAPL) and IBM's (IBM) announcement that they would be joining forces in the enterprise space.

There is no question that the move is a positive development for Apple, though it might not necessary lead to a large surge in sales. Why? Because Apple's iPhones and iPads are already present in more than 90% of America's major companies. And all this despite Apple having no enterprise sales force and, up until now, no major marketing efforts in the enterprise space.

Apple's products have always been designed for consumers first, but their popularity and versatility allowed them to spill over into the business world.

Bernie asked, somewhat skeptically, if Apple's sudden push into the enterprise space is due to a lack of other options. With the consumer market saturated, there is nowhere else to go. I agreed that this is true to an extent, but I think it’s also a sign of Apple's new maturity.

Think back to those old Mac commercials from 10-15 years ago that represented Apple as a trendy young guy and rival Microsoft (MSFT) as a bumbling middle-aged man in a cheap suit. Apple is no longer the young hipster; it's become the middle-aged man it used to make fun of.

That's OK. It's normal for companies to mature.

So, with all of this said, what does Apple's move mean for its competitors?

The biggest obvious loser is BlackBerry (BBRY), but BlackBerry is already so irrelevant at this point that I would argue that it won't make much of a difference.

It's definitely bad news for Google (GOOG), Samsung (SSNLF) and Microsoft, however, because all were themselves trying to build market share in the enterprise market, and this makes Apple a much more formidable competitor .

Charles Lewis Sizemore, CFA, is the editor of Macro Trend Investor and chief investment officer of the investment firm Sizemore Capital Management. As of this writing, he was long MSFT. Click here to receive his FREE weekly e-letter covering top market insights, trends, and the best stocks and ETFs to profit from today's best global value plays.

Wednesday, August 6, 2014

To Whip Your Wallet Into Shape, Ditch These 3 Toxic Mindsets

A man holding up his hands showing he has no money, isolated against a white background Shutterstock If you're trying to get your financial situation in order, you have to grapple with lot more than simply making the math work. Money is based in your mindset. If you're approaching money from a skewed perspective, even the best-laid plans won't bring you much success. Let's take a look at three of the most common bad money mindsets that can keep you from having a healthy relationship with money -- and how to get over them. 1. "Money Is the Root of All Evil" What it looks like in action: You feel guilty about earning and spending money. Maybe your parents drilled this mindset into you as a kid; maybe you developed it by watching their own financial struggles. Either way, you don't trust money and feel it leads to all sorts of ailments: stress, greed, you name it. The problem with this mindset: Money is not inherently evil; there are just good and bad ways to spend it. By dismissing it as troublesome, you're missing out on all of the good it can do in your life, from paying for your kids' education to helping out your favorite charity. How to fix it: You need to reprogram your brain to recognize money as something that is neither good or bad, but simply a tool. Figure out what ultimate goal you'd like to devote your money to and how you can get there. Reframing your money as a means to a positive end, and act accordingly. 2. "No One Gets Rich -- Unless They Win the Lottery" What it looks like in action: You just can't seem to get ahead, and you've resigned yourself to the notion that "that's just the way things are." You believe people who "make it" are lucky (or cheating the system) and you resent them for it, but you're also oddly proud of the way you're struggling and scrounging to make ends meet. The problem with this mindset: It's a self-fulfilling prophecy. Viewing life as an unending struggle -- and viewing money as a scarce resource that's hard to come by -- prevents you from creating the wealth that is very much within your reach. How to fix it: Take a long, hard look at those people who've "made it" and figure out what they did to get there. Sure, a few of them may have been handed a small fortune by the inheritance gods, but what about the rest? Maybe they dedicated themselves to professional development and put in long hours working their way up the ladder. Maybe they learned how to invest their money wisely and earned great returns. The same discipline and dedication you're using to live paycheck to paycheck could be transferred to a healthier goal that will pay off way more. 3. "I'm Just No Good with Money" What it looks like in action: You feel like there's always something waiting to go wrong with your finances -- and it's usually your fault. Every time you get a windfall, something winds up going wrong and eating it all up. You've wracked up a ton of debt and can't even remember why, and you have little hope that things will ever be any different -- you just seem to suck at money. The problem with this mindset: Even if you've made some really bad choices in the past, you can still change course. People have paid off tens of thousands of dollars of credit card debt and radically changed their financial outlook -- take a look at this couple that paid off $46,000 in credit-card debt. But you can't change anything if you've thrown up your hands and decided you're simply a dolt when it comes to money and there's no hope left for you. How to fix it: You need to get to the root of your bad money moves so you can learn from your mistakes and make a plan to avoid repeating them. Sit down with yourself and identify why you're in this situation. Are you prone to impulse purchases? Have you failed to stick to (or create) a budget? Once you know where things have gone wrong, you can work to set them right-so long as you believe it's in your power. More from Paula Pant
•10 Wedding Costs You Don't Want to Overlook •Recover From Your Money Mistakes in 6 Simple Steps •The 7 Worst Things You Can Do With a Pay Raise